{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:02:42Z","timestamp":1784768562539,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023NSFSC1106"],"award-info":[{"award-number":["2023NSFSC1106"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["QYJC2024-2"],"award-info":[{"award-number":["QYJC2024-2"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.taap.2026.117854","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:38:22Z","timestamp":1777995502000},"page":"117854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Onalespib enhances antitumor immunity through coordinated catalytic and chaperone-dependent regulation of tryptophan metabolism"],"prefix":"10.1016","volume":"512","author":[{"given":"Linhan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.117854_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.taap.2026.117854_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104753","article-title":"Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through control of cell heme allocation by nitric oxide","volume":"299","author":"Biswas","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2026.117854_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2022.01.008","article-title":"Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through GAPDH- and Hsp90-dependent control of their heme levels","volume":"180","author":"Biswas","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2026.117854_bb0020","first-page":"60","article-title":"Overcoming cancer drug resistance through small-molecule targeting of HSP90 and HSP70","volume":"8","author":"Cai","year":"2025","journal-title":"Cancer. Drug. Resist."},{"key":"10.1016\/j.taap.2026.117854_bb0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1097-2765(02)00450-1","article-title":"TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90","volume":"9","author":"Chen","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2026.117854_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122239","article-title":"Synergetic impact of combined navoximod with cisplatin mitigates chemo-immune resistance via blockading IDO1(+) CAFs-secreted Kyn\/AhR\/IL-6 and pol \u03b6-prevented CIN in human oral squamous cell carcinoma","volume":"335","author":"Chen","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2026.117854_bb0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41580-023-00640-9","article-title":"Structural and functional complexity of HSP90 in cellular homeostasis and disease","volume":"24","author":"Chiosis","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.taap.2026.117854_bb0040","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.1021\/acs.jmedchem.6b00718","article-title":"New inhibitors of Indoleamine 2,3-dioxygenase 1: molecular modeling studies, synthesis, and biological evaluation","volume":"59","author":"Coluccia","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2026.117854_bb0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2174\/0109298665333930240905111039","article-title":"A conserved tryptophan (Trp10) at the hydrophobic Core modulates the stability and inhibitory activity of potato I type inhibitors","volume":"31","author":"Cui","year":"2024","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.taap.2026.117854_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147517","article-title":"Immunotherapy in breast Cancer","volume":"25","author":"Dvir","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117854_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115203","article-title":"Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells","volume":"404","author":"Ebokaiwe","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2026.117854_bb0060","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/S1470-2045(19)30026-9","article-title":"Immunotherapy and targeted therapy combinations in metastatic breast cancer","volume":"20","author":"Esteva","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.taap.2026.117854_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/cmdc.201700666","article-title":"Improving the potency of Cancer immunotherapy by dual targeting of IDO1 and DNA","volume":"13","author":"Fang","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.taap.2026.117854_bb0070","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/bi00324a025","article-title":"Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation","volume":"24","author":"Fichtinger-Schepman","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.taap.2026.117854_bb0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/bs.acr.2015.10.001","article-title":"HSP90 and immune modulation in Cancer","volume":"129","author":"Graner","year":"2016","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.taap.2026.117854_bb0080","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20130066","article-title":"Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4","volume":"210","author":"Holmgaard","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2026.117854_bb0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2174\/0109298665363873250623103811","article-title":"Optimizing sleep in athletes: the potential of \u03b1-Lactalbumin in nutrition intervention","volume":"32","author":"Li","year":"2025","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.taap.2026.117854_bb0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.intimp.2017.03.024","article-title":"IDO1: an important immunotherapy target in cancer treatment","volume":"47","author":"Li","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2026.117854_bb0095","doi-asserted-by":"crossref","first-page":"15968","DOI":"10.1021\/acs.jmedchem.4c00966","article-title":"Targeting HSP90 for Cancer therapy: current Progress and emerging prospects","volume":"67","author":"Liang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2026.117854_bb0100","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2009-09-246124","article-title":"Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity","volume":"115","author":"Liu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.taap.2026.117854_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2017.07.014","article-title":"HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3","volume":"39","author":"Mahendrarajah","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.taap.2026.117854_bb0110","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.taap.2026.117854_bb0115","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nm1196","article-title":"Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy","volume":"11","author":"Muller","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2026.117854_bb0120","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/0109298665415743250926072254","article-title":"Cloning, expression, purification, and characterization of superoxide dismutase from the soil metagenome","volume":"32","author":"Nancy","year":"2025","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.taap.2026.117854_bb0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41419-022-05373-9","article-title":"HSP90 mediates the connection of multiple programmed cell death in diseases","volume":"13","author":"Peng","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2026.117854_bb0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.taap.2026.117854_bb0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2026.117854_bb0140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1158\/2326-6066.CIR-15-0057","article-title":"Targeting heat-shock protein 90 (HSP90) as a complementary strategy to immune checkpoint blockade for Cancer therapy","volume":"3","author":"Proia","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.taap.2026.117854_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pharmthera.2018.12.004","article-title":"Targeting indoleamine-2,3-dioxygenase in cancer: scientific rationale and clinical evidence","volume":"196","author":"Ricciuti","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2026.117854_bb0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrclinonc.2015.215","article-title":"Clinical relevance of host immunity in breast cancer: from TILs to the clinic","volume":"13","author":"Savas","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.taap.2026.117854_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-811X-7-17","article-title":"HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells","volume":"7","author":"Schoof","year":"2009","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.taap.2026.117854_bb0160","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1158\/1078-0432.CCR-12-3404","article-title":"First-in-human phase I dose-escalation study of the HSP90 inhibitor AUY922 in patients with advanced solid tumors","volume":"19","author":"Sessa","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2026.117854_bb0165","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1074\/jbc.M509901200","article-title":"The heat shock protein 90-CDC37 chaperone complex is required for signaling by types I and II interferons","volume":"281","author":"Shang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2026.117854_bb0170","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2026.117854_bb0175","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1158\/1078-0432.CCR-18-3212","article-title":"Pharmacodynamic and clinical results from a phase I\/II study of the HSP90 inhibitor Onalespib in combination with Abiraterone acetate in prostate Cancer","volume":"25","author":"Slovin","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2026.117854_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000255","article-title":"Targeting immune checkpoints in breast cancer: an update of early results","volume":"2","author":"Solinas","year":"2017","journal-title":"ESMO Open"},{"key":"10.1016\/j.taap.2026.117854_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2026.117854_bb0190","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2026.117854_bb0195","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2026.117854_bb0200","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ni1548","article-title":"\u2018Tuning\u2019 of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages","volume":"9","author":"Wang","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.taap.2026.117854_bb0205","article-title":"Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds","volume":"7","author":"Wang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.taap.2026.117854_bb0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.taap.2026.117854_bb0215","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.taap.2026.117854_bb0220","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bmc.2019.02.014","article-title":"4,6-substituted-1H-Indazoles as potent IDO1\/TDO dual inhibitors","volume":"27","author":"Yang","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.taap.2026.117854_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118195","article-title":"HSP90 inhibitors in cancer immunotherapy: therapeutic opportunities and challenges","volume":"301","author":"Zhang","year":"2026","journal-title":"Eur. J. Med. Chem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2600150X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2600150X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:40:57Z","timestamp":1784767257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2600150X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"alternative-id":["S0041008X2600150X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117854","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Onalespib enhances antitumor immunity through coordinated catalytic and chaperone-dependent regulation of tryptophan metabolism","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117854"}}